跳至主要内容
临床试验/NCT02016898
NCT02016898已完成2 期

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

Duke University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Complication Rates

研究概览

简要总结

The primary focus of this study is to assess intraocular pressure and complication rates between patients who receive mitomycin-C using a sponge versus no-sponge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged 18 years and older at screening.
  • Diagnosis of chronic angle-closure glaucoma or open-angle glaucoma, phakic or pseudophakic, with visual field or optic disc changes characteristic of glaucoma.
  • Suitable candidate for trabeculectomy with Ex-PRESS glaucoma filtration device with MMC in the superonasal quadrant in the study eye which the physician deems as medically necessary.
  • Capable and willing to provide consent

排除标准

  • Unable or unwilling to provide consent
  • Any previous ocular surgeries in the study eye preventing placement of the trabeculectomy with Ex-PRESS glaucoma filtration device with mitomycin-C in the superonasal quadrant
  • Any previous glaucoma drainage devices in the study eye
  • Any abnormality other than glaucoma in the study eye that could affect applanation tonometry.
  • Presence or history of any abnormality or disorder that could interfere with the study procedure or prevent the successful completion of the study.
  • Presence or history of uveitis within 10 years or any other ocular infection or inflammation within 14 days before day
  • Any significant unstable cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.
  • Known Pregnancy or Breastfeeding
  • Physical and Laboratory Findings
  • Conjunctival scarring precluding a superonasal implantation location.
  • Vitreous in the anterior chamber.
  • Abnormality preventing reliable applanation tonometry in the study eye.

研究组 & 干预措施

Sponge placement of Mitomycin-C

Experimental

Randomization will be stratified by age (age ≥65 or age < 65), baseline IOP (IOP ≥ 28 mmHg or IOP < 28 mmHg), and concurrent cataract surgery.

干预措施: Placement of the sponge (Procedure)

Sponge placement of Mitomycin-C

Experimental

Randomization will be stratified by age (age ≥65 or age < 65), baseline IOP (IOP ≥ 28 mmHg or IOP < 28 mmHg), and concurrent cataract surgery.

干预措施: Mitomycin-C (Drug)

Irrigation placement of Mitomycin-C

Experimental

Randomization will be stratified by age (age ≥65 or age < 65), baseline IOP (IOP ≥ 28 mmHg or IOP < 28 mmHg), and concurrent cataract surgery.

干预措施: Mitomycin-C (Drug)

结局指标

主要结局

Complication Rates

时间窗: post-operative day 1 to month 6

To assess complication rates between patients who receive mitomycin-C using a sponge versus irrigation

次要结局

  • Change in Intraocular Pressure(post-operative day 1 to month 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验